D
Dash Bio
Automated platform delivering accelerated, high-quality clinical bioanalysis for faster, better results
About Dash Bio
Dash Bio operates a cutting-edge, automated platform designed to revolutionize clinical bioanalysis by delivering high-quality results at unprecedented speeds. The company serves pharmaceutical and biotechnology firms, providing essential bioanalytical services from assay development and validation to sample analysis. Operating in the clinical research market, Dash Bio leverages its GLP-compliant laboratory to offer a core suite of assays that support in vivo and clinical studies. The business model focuses on providing rapid and reliable bioanalysis, which is crucial for drug development and regulatory submissions. Revenue is generated through service contracts with clients who require efficient and accurate bioanalytical data to advance their research and development projects. Dash Bio's commitment to innovation and quality positions it as a leader in the bioanalysis sector, driven by a team of inspired and curious professionals dedicated to transformative work. Keywords: automated platform, clinical bioanalysis, pharmaceutical, biotechnology, GLP-compliant, assay development, sample analysis, drug development, innovation, quality.
Source: Dealroom company dataLatest news
Press, funding announcements and product moves mentioning Dash Bio.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2026 | $30M | $120M | Oak HC/FT | ↗ |
| EARLY VC✓Equity / VC | Jul 2025 | $11M | $44M | Swift Ventures · Cybernetix Ventures · LifeX Ventures · The Aligned Fund | ↗ |
Growth signals
Latest recorded traffic for Dash Bio is 8.7K monthly website visits, up 262.5% over the last three months. Dash Bio's team grew 75% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 OrthoAIAI platform for dental diagnostics and claims. |
Abu Dhabi, United Arab Emirates | Operational | — | — | — |
 Kelter LLC-FZOn-demand phlebotomy and laboratory testing services. |
Dubai, United Arab Emirates | Operational | |||
 MiroDXHealth Tech & Medtech |
Dallas, United States | Operational | |||
 TreehubResidency program and fund for academic healthcare founders. |
United States | Operational | |||
 PetwealthAI-powered PCR diagnostics for proactive pet healthcare. |
Miami, United States | Operational | |||
 Juyin BiotechnologyPolygenic risk score analysis for disease prediction. |
China | Operational | |||
 DaliAI and digital twin modeling for healthcare decisions |
France | Operational | |||
 LuriaAI-powered software for personalized, holistic health analysis |
Los Angeles, United States | Operational |
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Freestyle Capital
Swift Ventures
LifeX Ventures
Series A4 investors entered at this stage
The Aligned Fund
Cybernetix Ventures
Drive Capital
Oak HC/FT
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dash Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dash Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.